Data for HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Organisation | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|
NORTH EAST STRATEGIC HEALTH … | 7313 | 8345 | 87.6% | 100 |
NCB London | 9830 | 11759 | 83.6% | 100 |
LONDON STRATEGIC HEALTH AUTHORITY | 9832 | 11762 | 83.6% | 90 |
YORKSHIRE AND THE HUMBER … | 9929 | 11920 | 83.3% | 80 |
NORTH WEST STRATEGIC HEALTH … | 15170 | 18385 | 82.5% | 70 |
NCB Midlands and East | 64636 | 78411 | 82.4% | 66 |
EAST MIDLANDS STRATEGIC HEALTH … | 9536 | 11576 | 82.4% | 60 |
UK | 114608 | 139581 | 82.1% | |
NHS England | 96177 | 117170 | 82.1% | |
SOUTH EAST COAST STRATEGIC … | 6600 | 8116 | 81.3% | 50 |
SOUTH CENTRAL STRATEGIC HEALTH … | 6137 | 7593 | 80.8% | 40 |
NCB South Region | 23060 | 28557 | 80.8% | 33 |
SOUTH WEST STRATEGIC HEALTH … | 10628 | 13219 | 80.4% | 30 |
WEST MIDLANDS STRATEGIC HEALTH … | 11085 | 13800 | 80.3% | 20 |
EAST OF ENGLAND STRATEGIC … | 9947 | 12454 | 79.9% | 10 |